Professional Documents
Culture Documents
Laporan Resmi - P1 - Ni Putu Desy A - 11370
Laporan Resmi - P1 - Ni Putu Desy A - 11370
Laporan Resmi - P1 - Ni Putu Desy A - 11370
PERCOBAAN I
PENCUCIAN DAN STERILISASI PENGEMAS
Disusun oleh :
Nama : Ni Putu Desy Anggraeni
NIM : 17/411941/FA/11370
Kelas/Golongan : C/II A
Hari/Jam Praktikum : Kamis/11.00-15.00
Tanggal Praktikum : 5 Maret 2020
Dosen Pembimbing : Dr. Eng. Khadijah, M.Si., Apt.
1 Nonproprietary Names In the USP 32, the term ‘dehydrated alcohol’ refers to ethanol
BP: Ethanol (96%) 599.5% v/v. The term ‘alcohol’ without other qualification refers
to ethanol 94.9–96.0% v/v.
JP: Ethanol In the JP XV, ethanol (alcohol) contains 95.1–96.9% v/v (by
PhEur: Ethanol (96 per cent) specific gravity) of C2H6O at 158C.
USP: Alcohol In the Handbook of Pharmaceutical Excipients, the term
‘alcohol’ is used for either ethanol 95% v/v or ethanol 96% v/v.
2 Synonyms Alcohol is a clear, colorless, mobile, and volatile liquid with a
slight, characteristic odor and burning taste.
Ethanolum (96 per centum); ethyl alcohol; ethyl hydroxide; grain
See also Section 17.
alcohol; methyl carbinol.
9 Pharmacopeial Specifications
3 Chemical Name and CAS Registry Number
See Table II. See also Sections 17 and 18.
Ethanol [64-17-5]
Table II: Pharmacopeial specifications for alcohol.
4 Empirical Formula and Molecular Weight
C2H6O 46.07 Test JP XV PhEur 6.0 USP 32
Identification þ þ þ
5 Structural Formula Characters — þ —
Specific gravity 0.809–0.816 0.805–0.812 0.812–0.816
Acidity or alkalinity þ þ þ
Clarity and color of þ þ þ
solution
Nonvolatile residue 42.5 mg 425 ppm 42.5 mg
Volatile impurities þ þ þ
6 Functional Category Absorbance þ þ þ
Antimicrobial preservative; disinfectant; skin penetrant; solvent. at 240 nm 40.40 40.40 40.40
at 250–260 nm 40.30 40.30 40.30
at 270–340 nm 40.10 40.10 40.10
7 Applications in Pharmaceutical Formulation or Assay 95.1–96.9% 95.1–96.9% 92.3–93.8%
Technology by weight
Ethanol and aqueous ethanol solutions of various concentrations 94.9–96.0%
(see Sections 8 and 17) are widely used in pharmaceutical by volume
formulations and cosmetics; see Table I. Although ethanol is
primarily used as a solvent, it is also employed as a disinfectant, and
in solutions as an antimicrobial preservative.(1,2) Topical ethanol 10 Typical Properties
solutions are used in the development of transdermal drug delivery
systems as penetration enhancers.(3–10) Ethanol has also been used Antimicrobial activity Ethanol is bactericidal in aqueous mix-
in the development of transdermal preparations as a co-surfac- tures at concentrations between 60% and 95% v/v; the optimum
tant.(11–13) concentration is generally considered to be 70% v/v. Antimicro-
bial activity is enhanced in the presence of edetic acid or edetate
salts.(1) Ethanol is inactivated in the presence of nonionic
Table I: Uses of alcohol.
surfactants and is ineffective against bacterial spores.
Use Concentration (% v/v) Boiling point 78.158C
Flammability Readily flammable, burning with a blue, smokeless
Antimicrobial preservative 510 flame.
Disinfectant 60–90
Extracting solvent in galenical manufacture Up to 85
Flash point 148C (closed cup)
Solvent in film coating Variable NIR spectra see Figures 1 and 2.
Solvent in injectable solutions Variable Solubility Miscible with chloroform, ether, glycerin, and water
Solvent in oral liquids Variable (with rise of temperature and contraction of volume).
Solvent in topical products 60–90 Specific gravity 0.8119–0.8139 at 208C
Note The above typical properties are for alcohol (ethanol 95% or
96% v/v). See Section 17 for typical properties of dehydrated
alcohol.
8 Description
In the BP 2009, the term ‘ethanol’ used without other qualification 11 Stability and Storage Conditions
refers to ethanol containing 599.5% v/v of C2H6O. The term
Aqueous ethanol solutions may be sterilized by autoclaving or by
‘alcohol’, without other qualification, refers to ethanol 95.1–96.9%
filtration and should be stored in airtight containers, in a cool place.
v/v. Where other strengths are intended, the term ‘alcohol’ or
‘ethanol’ is used, followed by the statement of the strength.
In the PhEur 6.0, anhydrous ethanol contains not less than 12 Incompatibilities
99.5% v/v of C2H6O at 208C. The term ethanol (96%) is used to In acidic conditions, ethanol solutions may react vigorously with
describe the material containing water and 95.1–96.9% v/v of oxidizing materials. Mixtures with alkali may darken in color
C2H6O at 208C. owing to a reaction with residual amounts of aldehyde. Organic
17
18 Alcohol
2.0
A
6.0 2292 Although symptoms of ethanol intoxication are usually encoun-
1000 × [2nd deriv. log(1/R)] 2252
2338
tered following deliberate consumption of ethanol-containing
2369 beverages, many pharmaceutical products contain ethanol as a
1671 solvent, which, if ingested in sufficiently large quantities, may cause
adverse symptoms of intoxication. In the USA, the maximum
1og(1/R)
0.0 quantity of alcohol included in OTC medicines is 10% v/v for
1185
1938
2076 products labeled for use by people of 12 years of age and older, 5%
1692 1734 v/v for products intended for use by children aged 6–12 years of age,
2463
and 0.5% v/v for products for use by children under 6 years of
age.(14)
Parenteral products containing up to 50% of alcohol (ethanol 95
2354 or 96% v/v) have been formulated. However, such concentrations
2270 2309 can produce pain on intramuscular injection and lower concentra-
−9.0 0.0 tions such as 5–10% v/v are preferred. Subcutaneous injection of
1100 1300 1500 1700 1900 2100 2300 2500
alcohol (ethanol 95% v/v) similarly causes considerable pain
Wavelength/nm followed by anesthesia. If injections are made close to nerves,
neuritis and nerve degeneration may occur. This effect is used
Figure 1: Near-infrared spectrum of alcohol (96%) measured by therapeutically to cause anesthesia in cases of severe pain, although
transflectance (1 mm path-length). the practice of using alcohol in nerve blocks is controversial. Doses
6.0 2.0 of 1 mL of absolute alcohol have been used for this purpose.(15)
1000 × [2nd deriv. log(1/R)]
2292 2339
2252
Preparations containing more than 50% v/v alcohol may cause
2369 skin irritation when applied topically.
1671
LD50 (mouse, IP): 0.93 g/kg(16)
LD50 (mouse, IV): 1.97 g/kg
1og(1/R)
0.0
1185 2078
LD50 (mouse, oral): 3.45 g/kg
1692 1734 LD50 (mouse, SC): 8.29 g/kg
LD50 (rat, IP): 3.75 g/kg
2462
LD50 (rat, IV): 1.44 g/kg
LD50 (rat, oral): 7.06 g/kg
2355
2270 2309
−9.0 0.0 15 Handling Precautions
1100 1300 1500 1700 1900 2100 2300 2500
Observe normal precautions appropriate to the circumstances and
Wavelength/nm quantity of material handled. Ethanol and aqueous ethanol
solutions should be handled in a well-ventilated environment. In
Figure 2: Near-infrared spectrum of alcohol (absolute) measured by the UK, the long-term 8-hour TWA workplace exposure limit for
transflectance (1 mm path-length). ethanol is 1920 mg/m3 (1000 ppm).(17) Ethanol may be irritant to
the eyes and mucous membranes, and eye protection and gloves are
recommended. Ethanol is flammable and should be heated with
salts or acacia may be precipitated from aqueous solutions or care. Fixed storage tanks should be electrically grounded to avoid
dispersions. Ethanol solutions are also incompatible with aluminum ignition from electrostatic discharges when ethanol is transferred.
containers and may interact with some drugs.
16 Regulatory Status
13 Method of Manufacture
Included in the FDA Inactive Ingredients Database (dental
Ethanol is manufactured by the controlled enzymatic fermentation preparations; inhalations; IM, IV, and SC injections; nasal and
of starch, sugar, or other carbohydrates. A fermented liquid is ophthalmic preparations; oral capsules, solutions, suspensions,
produced containing about 15% ethanol; ethanol 95% v/v is then syrups, and tablets; rectal, topical, and transdermal preparations).
obtained by fractional distillation. Ethanol may also be prepared by Included in the Canadian List of Acceptable Non-medicinal
a number of synthetic methods. Ingredients. Included in nonparenteral and parenteral medicines
licensed in the UK.
14 Safety
Ethanol and aqueous ethanol solutions are widely used in a variety 17 Related Substances
of pharmaceutical formulations and cosmetics. It is also consumed Dehydrated alcohol; denatured alcohol; dilute alcohol; isopropyl
in alcoholic beverages. alcohol.
Ethanol is rapidly absorbed from the gastrointestinal tract and Dehydrated alcohol
the vapor may be absorbed through the lungs; it is metabolized, Synonyms Absolute alcohol; anhydrous ethanol; ethanol.
mainly in the liver, to acetaldehyde, which is further oxidized to Autoignition temperature 3658C
acetate. Boiling point 78.58C
Ethanol is a central nervous system depressant and ingestion of Explosive limits 3.5–19.0% v/v in air
low to moderate quantities can lead to symptoms of intoxication Flash point 128C (closed cup)
including muscle incoordination, visual impairment, slurred speech, Melting point 1128C
etc. Ingestion of higher concentrations may cause depression of Moisture content Absorbs water rapidly from the air.
medullary action, lethargy, amnesia, hypothermia, hypoglycemia, Refractive index n 20D = 1.361
stupor, coma, respiratory depression, and cardiovascular collapse. Specific gravity 0.7904–0.7935 at 208C
The lethal human blood-alcohol concentration is generally esti- Surface tension 22.75 mN/m at 208C (ethanol/vapor)
mated to be 400–500 mg/100 mL. Vapor density (relative) 1.59 (air = 1)
Alcohol 19
A
Vapor pressure 5.8 Pa at 208C 2 Karabit MS et al. Studies on the evaluation of preservative efficacy. IV.
Viscosity (dynamic) 1.22 mPa s (1.22 cP) at 208C The determination of antimicrobial characteristics of some pharma-
Comments Dehydrated alcohol is ethanol 599.5% v/v. See ceutical compounds in aqueous solutions. Int J Pharm 1989; 54: 51–56.
3 Liu P et al. Quantitative evaluation of ethanol effects on diffusion and
Section 8. Dehydrated alcohol is one of the materials that have
metabolism of b-estradiol in hairless mouse skin. Pharm Res 1991; 8(7):
been selected for harmonization by the Pharmacopeial Discus- 865–872.
sion Group. For further information see the General Information 4 Verma DD, Fahr A. Synergistic penetration enhancement of ethanol and
Chapter <1196> in the USP32–NF27, the General Chapter 5.8 phospholipids on the topical delivery of cyclosporin A. J Control
in PhEur 6.0, along with the ‘State of Work’ document on the Release 2004; 97(1): 55–66.
PhEur EDQM website, and also the General Information 5 Gwak SS et al. Transdermal delivery of ondansetron hydrochloride:
effects of vehicles and penetration enhancers. Drug Dev Ind Pharm
Chapter 8 in the JP XV.
2004; 30(2): 187–194.
Denatured alcohol 6 Williams AC, Barry BW. Penetration enhancers. Adv Drug Delivery Rev
Synonyms Industrial methylated spirit; surgical spirit. 2004; 56(5): 603–618.
Comments Denatured alcohol is alcohol intended for external use 7 Heard CA et al. Skin penetration enhancement of mefenamic acid by
ethanol and 1,8-cineole can be explained by the ‘pull’ effect. Int J Pharm
only. It has been rendered unfit for human consumption by the 2006; 321: 167–170.
addition of a denaturing agent such as methanol or methyl 8 Rhee YS et al. Effects of vehicles and enhancers on transdermal delivery
isobutyl ketone. of clebopride. Arch Pharm Res 2007; 30: 1155–1161.
9 Fang C et al. Synergistically enhanced transdermal permeation and
Dilute alcohol topical analgesia of tetracaine gel containing menthol and ethanol in
Synonyms Dilute ethanol. experimental and clinical studies. Eur J Pharm Biopharm 2008; 68:
Specific gravity see Table III. 735–740.
10 Krishnaiah YS et al. Penetration-enhancing effect of ethanolic solution
Table III: Specific gravity of alcohol. of menthol on transdermal permeation of ondansetron hydrochloride
across rat epidermis. Drug Deliv 2008; 15: 227–234.
Strength of alcohol (% v/v) Specific gravity at 208C 11 Kweon JH et al. Transdermal delivery of diclofenac using microemul-
sions. Arch Pharmacol Res 2004; 27(3): 351–356.
90 0.8289–0.8319 12 Huang YB et al. Transdermal delivery of capsaicin derivative-sodium
80 0.8599–0.8621 nonivamide acetate using microemulsions as vehicles. Int J Pharm
70 0.8860–0.8883 2008; 349: 206–211.
60 0.9103–0.9114 13 El Maghraby GM. Transdermal delivery of hydrocortisone from
50 0.9314–0.9326 eucalyptus oil microemulsion: effects of cosurfactants. Int J Pharm
45 0.9407–0.9417 2008; 355: 285–292.
25 0.9694–0.9703 14 Jass HE. Regulatory review. Cosmet Toilet 1995; 110(5): 21–22.
20 0.9748–0.9759 15 Lloyd JW. Use of anaesthesia: the anaesthetist and the pain clinic. Br
Med J 1980; 281: 432–434.
Comments The term ‘dilute alcohol’ refers to a mixture of ethanol 16 Lewis RJ, ed. Sax’s Dangerous Properties of Industrial Materials, 11th
and water of stated concentration. The USP32–NF27 lists edn. New York: Wiley, 2004; 1627–1628.
17 Health and Safety Executive. EH40/2005: Workplace Exposure Limits.
diluted alcohol. The BP 2009 lists eight strengths of dilute Sudbury: HSE Books, 2005 (updated 2007). http://www.hse.gov.uk/
alcohol ( dilute ethanol) containing 90%, 80%, 70%, 60%, coshh/table1.pdf (accessed 5 February 2009).
50%, 45%, 25%, and 20% v/v respectively of ethanol. 18 Food Chemicals Codex, 6th edn. Bethesda, MD: United States
Pharmacopeia, 2008; 303.
18 Comments
Alcohol is one of the materials that have been selected for 20 General References
harmonization by the Pharmacopeial Discussion Group. For further European Directorate for the Quality of Medicines and Healthcare
information see the General Information Chapter <1196> in the (EDQM). European Pharmacopoeia – State Of Work Of International
Harmonisation. Pharmeuropa 2009; 21(1): 142–143. http://www.edq-
USP32–NF27, the General Chapter 5.8 in PhEur 6.0, along with the m.eu/site/-614.html (accessed 3 February 2009).
‘State of Work’ document on the PhEur EDQM website, and also Lund W, ed. The Pharmaceutical Codex: Principles and Practice of
the General Information Chapter 8 in the JP XV. Pharmaceutics, 12th edn. London: Pharmaceutical Press, 1994; 694–
Possession and use of nondenatured alcohols are usually subject 695.
to close control by excise authorities. Spiegel AJ, Noseworthy MN. Use of nonaqueous solvents in parenteral
A specification for alcohol is contained in the Food Chemicals products. J Pharm Sci 1963; 52: 917–927.
Wade A, ed. Pharmaceutical Handbook, 19th edn. London: Pharmaceutical
Codex (FCC).(18) Press, 1980; 227–230.
The EINECS number for alcohol is 200-578-6. The PubChem
Compound ID (CID) for alcohol is 702.
21 Author
19 Specific References ME Quinn.
1 Chiori CO, Ghobashy AA. A potentiating effect of EDTA on the
bactericidal activity of lower concentrations of ethanol. Int J Pharm 22 Date of Revision
1983; 17: 121–128. 5 February 2009.
Hydrochloric Acid
5 Structural Formula Solubility Miscible with water; soluble in diethyl ether, ethanol
(95%), and methanol.
See Section 4.
11 Stability and Storage Conditions
Hydrochloric acid should be stored in a well-closed, glass or other
6 Functional Category inert container at a temperature below 308C. Storage in close
proximity to concentrated alkalis, metals, and cyanides should be
Acidifying agent.
avoided.
12 Incompatibilities
7 Applications in Pharmaceutical Formulation or Hydrochloric acid reacts violently with alkalis, with the evolution of
Technology a large amount of heat. Hydrochloric acid also reacts with many
Hydrochloric acid is widely used as an acidifying agent, in a variety metals, liberating hydrogen.
of pharmaceutical and food preparations (see Section 16). It may
also be used to prepare dilute hydrochloric acid, which in addition 13 Method of Manufacture
to its use as an excipient has some therapeutic use, intravenously in Hydrochloric acid is an aqueous solution of hydrogen chloride gas
the management of metabolic alkalosis, and orally for the treatment produced by a number of methods including: the reaction of sodium
of achlorhydria. See Section 17. chloride and sulfuric acid; the constituent elements; as a by-product
from the electrolysis of sodium hydroxide; and as a by-product
during the chlorination of hydrocarbons.
8 Description 14 Safety
Hydrochloric acid occurs as a clear, colorless, fuming aqueous When used diluted, at low concentration, hydrochloric acid is not
solution of hydrogen chloride, with a pungent odor. usually associated with any adverse effects. However, the concen-
The JP XV specifies that hydrochloric acid contains 35.0–38.0% trated solution is corrosive and can cause severe damage on contact
w/w of HCl; the PhEur 6.0 specifies that hydrochloric acid contains with the eyes and skin, or if ingested.
35.0–39.0% w/w of HCl; and the USP32–NF27 specifies that
hydrochloric acid contains 36.5–38.0% w/w of HCl. See also LD50 (mouse, IP): 1.4 g/kg(1)
Section 9. LD50 (rabbit, oral): 0.9 g/kg
15 Handling Precautions
Caution should be exercised when handling hydrochloric acid, and
9 Pharmacopeial Specifications suitable protection against inhalation and spillage should be taken.
See Table I. Eye protection, gloves, face mask, apron, and respirator are
3 08
Hydrophobic Colloidal Silica 30 9
H
Acceptable Non-medicinal Ingredients.
London: Pharmaceutical Press, 2009; 2322.
4 Food Chemicals Codex, 6th edn. Bethesda, MD: United States
17 Related Substances Pharmacopeia, 2008; 458.
Dilute hydrochloric acid.
Dilute hydrochloric acid 20 General References
Synonyms Acidum hydrochloridum dilutum; diluted hydrochlo- Japan Pharmaceutical Excipients Council. Japanese Pharmaceutical Exci-
ric acid. pients Directory 1996. Tokyo: Yakuji Nippo, 1996; 228.
Density 1.05 g/cm3 at 208C
Comments The JP XV and PhEur 6.0 specify that dilute 21 Authors
hydrochloric acid contains 9.5–10.5% w/w of HCl and is ME Quinn, PJ Sheskey.
prepared by mixing 274 g of hydrochloric acid with 726 g of
water. The USP32–NF27 specifies 9.5–10.5% w/v of HCl,
prepared by mixing 226 mL of hydrochloric acid with sufficient 22 Date of Revision
water to make 1000 mL. 5 February 2009.
8 Description 8
Sodium carbonate is a white, almost white, or colorless inorganic
salt, produced as crystalline powder or granules. It is hygroscopic 4
and odorless with an alkaline taste. 0 20 40 60 80 100
Temperature (°C)
9 Pharmacopeial Specifications
Figure 1: Solubility of sodium carbonate in water.(5) Adapted with
See Table I. permission.
63 5
6 36 Sodium Carbonate
11 Stability and Storage Conditions Comments Listed in PhEur 6.0 and JP XV. Used in alkaline
Sodium carbonate converts to the monohydrate form when in baths.(4)
contact with water and produces heat. It begins to lose carbon Sodium carbonate monohydrate
dioxide at temperatures above 4008C(7) and decomposes before Empirical formula Na2CO3H2O
boiling. Store in airtight containers. Molecular weight 124.0
CAS number [5968-11-6]
12 Incompatibilities Description Colorless or white crystals or granules.
Sodium carbonate decomposes when in contact with acids in the Solubility Soluble in 3 parts water, 1.8 parts boiling water, or 7
presence of water to produce carbon dioxide and effervescence. It parts glycerin. Practically insoluble in ethanol (95%). Dries out
may react violently with aluminum, phosphorous pentoxide, in warm dry air or above 508C, and converts to anhydrous form
sulfuric acid, fluorine, and lithium. above 1008C.
Comments Listed in PhEur 6.0 and USP32–NF27. Commonly
used in antacid preparations and as a reagent.(4)
13 Method of Manufacture
Sodium carbonate is produced by the ammonia-soda process, also 18 Comments
known as the Solvay process.(7)
Sodium carbonate is more stable in effervescent formulations than
sodium bicarbonate,(3) but is less effective as an effervescent agent
14 Safety
and therefore sodium bicarbonate is most commonly used in
Sodium carbonate is used in injectable, oral, and rectal pharma- effervescent formulations.(2) Sodium carbonate can be added to
ceutical formulations. The pure form of sodium carbonate is mildly these formulations as a stabilizing agent (up to 10% w/w) as it
toxic by ingestion, moderately toxic by inhalation and SC routes, absorbs moisture, preventing early effervescent reactions.(2) This
and very toxic by the IP route. It is irritating to the skin and eyes. effect is exploited in Effer-Soda, in which a sodium bicarbonate core
Dust and vapors of sodium carbonate may irritate mucous is protected by a surface layer of sodium carbonate, equivalent to
membranes, causing coughing and shortness of breath. It also has 8–12% w/w.(9)
experimental reproductive effects. The technical grade of sodium carbonate anhydrous (approxi-
Sodium carbonate can migrate to food from packaging mately 99% purity) is known as soda ash.
materials. When used as an excipient or antacid, sodium carbonate A specification for sodium carbonate is contained in the Food
is generally regarded as a nontoxic and nonirritating material. Chemicals Codex (FCC).(10)
LD50 (mouse, IP): 0.12 g/kg(8) The EINECS number for sodium carbonate is 207-838-8. The
PubChem Compound ID (CID) for sodium carbonate is 10340.
LD50 (mouse, SC): 2.21 g/kg
LD50 (rat, oral): 4.09 g/kg
19 Specific References
1 Niazi S. Compressed solid dosage formulations. Niazi SK, ed. Hand-
15 Handling Precautions book of Pharmaceutical Manufacturing Formulations, vol. 1: Part II.
Observe normal precautions appropriate to the circumstances and Boca Raton FL: CRC Press, 2004.
quantity of the material handled. When heated to decomposition it 2 Bertuzzi D. Effervescent granulation. Parikh D, ed. Handbook of
emits toxic fumes of sodium oxide. Eye protection and gloves are Pharmaceutical Granulation Technology, 2nd edn. Boca Raton FL:
recommended. Respiratory protection is also recommended if Taylor and Francis, 2005; 365.
inhalable dust is present. 3 Badawy S et al. Effect of processing and formulation variables on the
stability of a salt of a weakly basic drug candidate. Pharm Dev Technol
2004; 9: 239–245.
16 Regulatory Status 4 Sweetman SC, ed. Martindale: the Complete Drug Reference, 36th edn.
S GRAS listed. Accepted for use as a food additive in Europe. London: Pharmaceutical Press, 2009; 2389.
Included in the FDA Inactive Ingredients Database (injections; 5 Eggeman T. Sodium carbonate.Kirk-Othmer Encyclopedia of Chemical
Technology, 5th edn, vol. 22: New York: Wiley, 2001; 787–797.
ophthalmic solution; oral capsules and tablets; rectal suspensions).
6 Lide DR, ed. CRC Handbook of Chemistry and Physics, 88th edn.
Included in the Canadian List of Acceptable Non-medicinal Boca Raton FL: CRC Press/Taylor and Francis, 2008; 8–52.
Ingredients. Included in parenteral (powder for solution for 7 O’Neil MJ, ed. Merck Index: An Encyclopedia of Chemicals, Drugs and
injection) and nonparenteral medicines (oral effervescent tablets, Biologicals, 14th edn. Whitehouse Station NJ: Merck, 2006; 1480–
soluble tablets, granules, lozenges, chewing gums) licensed in the 1481.
UK. 8 Lewis RJ, ed. Sax’s Dangerous Properties of Industrial Chemicals, 11th
USP32–NF27 allows either the anhydrous or the monohydrate edn. New York: Wiley, 2004; 3236.
form. 9 SPI Pharma. Technical Bulletin No. 117/0300: Effer-Soda, 2007.
10 Food Chemicals Codex, 6th edn. Bethesda, MD: United States
Pharmacopeia, 2008; 878.
17 Related Substances
Sodium bicarbonate; sodium carbonate decahydrate; sodium 20 General References
carbonate monohydrate.
—
Sodium carbonate decahydrate
Empirical formula Na2CO310H2O 21 Author
Molecular weight 286.1
KP Hapgood.
CAS number [6132-02-1]
Description Colorless, transparent, or white crystals or powder.
Solubility Freely soluble in water; practically insoluble in ethanol 22 Date of Revision
(95%). 3 March 2009.
W
Water
1 Nonproprietary Names purified water, water for injection (WFI), sterile water for injection,
BP: Purified Water bacteriostatic water for injection, sterile water for irrigation, or
sterile water for inhalation. Validation is required for all systems
JP: Purified Water
producing the water indicated, with the exception of potable water.
PhEur: Water, Purified The chemical composition of potable water is variable, and the
USP: Purified Water nature and concentrations of the impurities in it depend upon the
See also Sections 8 and 17. source from which it is drawn. Water classified as potable water for
applications such as some initial rinsing and API manufacturing
2 Synonyms operations, must meet the US Environmental Protection Agency’s
National Primary Drinking Water Regulations, or comparable
Aqua; aqua purificata; hydrogen oxide.
regulations of the EU or Japan. For most pharmaceutical applica-
tions, potable water is purified by distillation, ion exchange
3 Chemical Name and CAS Registry Number
treatment, reverse osmosis (RO), or some other suitable process
Water [7732-18-5] to produce ‘purified water’. For certain applications, water with
pharmacopeial specifications differing from those of purified water
4 Empirical Formula and Molecular Weight should be used, e.g. WFI; see Sections 9 and 18.
H2 O 18.02 Water is a clear, colorless, odorless, and tasteless liquid.
5 Structural Formula
See Section 4. 9 Pharmacopeial Specifications
See Table II. See also Section 17.
6 Functional Category
Solvent.
of parenteral products.
Sterile water for inhalation Diluent for inhalation therapy
products.
11 Stability and Storage Conditions
Sterile water for injection Diluent for injections.
Sterile water for irrigation Diluent for internal irrigation therapy Water is chemically stable in all physical states (ice, liquid, and
products. vapor). Water leaving the pharmaceutical purification system and
Water for injections in bulk Water for the bulk preparation of entering the storage tank must meet specific requirements. The goal
medicines for parenteral
when designing and operating the storage and distribution system is
administration.
to keep the water from exceeding allowable limits during storage. In
particular, the storage and distribution system must ensure that
water is protected against ionic and organic contamination, which
8 Description would lead to an increase in conductivity and total organic carbon,
The term ‘water’ is used to describe potable water that is freshly respectively. The system must also be protected against physical
drawn direct from the public supply and is suitable for drinking. entry of foreign particles and microorganisms so that microbial
Water used in the pharmaceutical industry and related disciplines is growth is prevented or minimized. Water for specific purposes
classified as either drinking (potable) water, purified water, sterile should be stored in appropriate containers; see Table III.
7 66
Table II: Pharmacopeial specifications of water for different pharmaceutical applications.
Test Water Purified Purified Purified Purified Water, Sterile Bacteriostatic Sterile Sterile Sterile Water for Water for Water for Sterile Sterile
JP XV water water in water in water highly water for water for water for water for purified injection(a) injection injection water for purified
JP XV bulk containers USP 32 purified injection injection inhalation irrigation water JP XV USP 32 (in bulk) injection water
PhEur 6.3 PhEur 6.3 PhEur 6.3 USP 32 USP 32 USP 32 USP 32 USP 32 PhEur 6.3 PhEur 6.3 JP XV
Identification — — — — — — — — — — — — — — — —
Production — — þ — — þ — — — — — — — þ — —
Characters — — þ þ — þ — — — — — — — þ — —
Appearance of solution — þ — — — — — — — — — — — — — þ
Odor and taste — þ — — — — — — — — — — — — — þ
pH — — — — — — 5.0–7.0 4.5–7.0 — — — — — — — —
Acid or alkali — þ — þ — — — — — — — þ — — þ þ
Cadmium — — — — — — — — — — — — — — — —
Chloride — þ — þ — — þ — — — — — þ — þ þ
Cyanide — — — — — — — — — — — — — — — —
Copper — — — — — — — — — — — — — — — —
Sulfate — þ — þ — — þ þ — — — þ — — þ þ
Ammonium 40.05 mg/L 40.05 mg/L — 40.2 ppm — — þ — — — — þ — — 40.2 ppm 40.05 mg/L
Iron — — — — — — — — — — — — — — — —
Calcium — — — þ — — þ þ — — — — — — þ —
Lead — — — — — — — — — — — — — — — —
Magnesium — — — þ — — — — — — — — — — þ —
Aluminum — — 410 ppb — — 410 ppb — — — — — — — 410 ppb 410 ppb —
Nitrate — — 40.2 ppm — — 40.2 ppm — — — — — — — 40.2 ppm 40.2 ppm þ
Nitrogen from nitrate — þ — — — — — — — — — þ — — — þ
Nitrogen from nitrite — þ — — — — — — — — — þ — — — þ
Carbon dioxide — — — — — — þ þ — — — — — — — —
Heavy metals — þ 40.1 ppm — — — — — — — — þ — — — þ
Oxidizable substances — — þ þ — — þ — þ þ þ — — — þ —
Potassium — þ — — — — — — — — — þ — — — þ
permanganate-
reducing substances
Residue on evaporation — 41.0 mg — 40.001% — — — — — — — þ — — þ 41.0 mg
Total organic carbon — — þ — þ 40.5 mg/L — — — — — þ(b) þ 40.5 mg/L — —
Total hardness — — — — — — — — — — — — — — — —
Conductivity — — þ — þ þ — — 425 mS/cm for 425 mS/cm for 425 mS/cm — þ þ 425 mS/cm for —
containers containers for containers containers
410 mL, 410 mL, 410 mL, 410 mL,
45 mS/cm 45 mS/cm 45 mS/cm for 45 mS/cm
for containers for containers containers for containers
510 ml 510 ml 510 ml 510 ml
Anionic surfactants — — — — — — — — — — — — — — — —
Antimicrobial agents — — — — — — — þ — — — — — — — —
Sterility — — — — — — þ þ þ þ þ þ — — þ þ
Extractable volume — — — — — — — — — — — þ — — — —
Particulate matter — — — — — — þ þ — — — — — — þ —
Microbial contamination — — — 4102 cfu/mL — — — — — — — — — — — —
Bacterial endotoxins — — 40.25 IU/mL — — 40.25 IU/mL 40.25 EU/mL <0.5 EU/mL <0.5 EU/mL 40.25 EU/mL — 40.25 EU/mL 40.25 EU/mL 40.25 IU/mL <0.25 IU/mL —
(a) For water for injection preserved in containers and sterilized, the JP XV provides separate tests for acid or alkali, chloride, ammonium, and residue on evaporation within the monograph.
(b) For water for injection prepared by reverse osmosis–ultrafiltration.
Water
76 7
W
7 68 Water
Table III: Storage requirements for different grades of water. exchange, RO or any other suitable method that complies with
regulations on water intended for human consumption laid down
Type Storage requirements(a) by the competent authority. The USP 32 and the JP XV permit the
Bacteriostatic water for injection Preserve in single-dose and multiple-
use of RO in addition to distillation and ultrafiltration. In the past
dose containers, preferably of 10–15 years, RO has become the most common way to produce
Type I or Type II glass, not larger pharmaceutical purified water, either as a final treatment step or as a
than 30 mL in size. pretreatment step for the distillation stills.
Potable water Preserve in tightly sealed containers. Distillation Distillation is a process that involves the evaporation
Purified water Preserve in tightly sealed containers. of water followed by the condensation of the resulting steam.
If it is stored in bulk, the conditions While expensive, it allows removal of almost all organic and
of storage should be designed to inorganic impurities and achieves very high quality water. It is
limit the growth of microorganisms
and avoid any other also considered the safest method to avoid microbial and
contamination. endotoxin contamination. To improve energy efficiency, distilla-
Sterile water for inhalation Preserve in single-dose containers, tion is usually conducted in multiple-effects stills designed to
preferably of Type I or Type II recover most of the energy spent on evaporating the water. A
glass. typical design consists of an evaporator, vapor separator, and
Sterile water for injection Preserve in single-dose containers, compressor. The distilland (raw feed water) is heated in the
preferably of Type I or Type II evaporator to boiling and the vapor produced is separated from
glass, not more than 1000 mL in
entrained distilland in the separator. The vapor then enters a
size.
Water for injection Preserve in tightly sealed containers. compressor where the temperature of the vapors is raised to
Water for injections in bulk Collect and store in conditions 1078C. Superheated vapors are then condensed on the outer
designed to prevent growth of surface of the tubes of the evaporator containing cool distilland
microorganisms and avoid any circulating within.
other contamination. Vapor compression stills of various sizes are commercially
available and can be used to produce water of high purity when
(a) To prevent evaporation and to maintain quality.
properly constructed. A high-quality distillate, such as WFI, can
be obtained if the water is first deionized. The best stills are
constructed from types 304 or 316 stainless steel and coated with
12 Incompatibilities pure tin, or are made from chemical-resistant glass.
In pharmaceutical formulations, water can react with drugs and Deionization An ionic exchange process is based on the ability of
other excipients that are susceptible to hydrolysis (decomposition in certain synthetic resins to selectively adsorb either cations or
the presence of water or moisture) at ambient and elevated anions, and to release (exchange) other ions based on their
temperatures. relative activity. Cationic and anionic ion exchange resins are
Water can react violently with alkali metals and rapidly with used to purify potable water by removing any dissolved ions.
alkaline metals and their oxides, such as calcium oxide and Dissolved gases are also removed, while chlorine, in the
magnesium oxide. Water also reacts with anhydrous salts to form concentrations generally found in potable water, is destroyed
hydrates of various compositions, and with certain organic by the resin itself. Some organics and colloidal particles are
materials and calcium carbide. removed by adsorption and filtration. Resin beds may, however,
foster microbial life and produce pyrogenic effluent unless
13 Method of Manufacture adequate precautions are taken to prevent contamination.
Unlike other excipients, water is not purchased from outside Another disadvantage is the type of chemicals required for resin
suppliers but is manufactured in-house by pharmaceutical compa- regeneration. A continuous deionization system, which repre-
nies. As naturally occurring water has a variety of contaminants, sents a combination of ion exchange and membrane separation
many treatment processes have been developed to remove these. A technologies, uses an electrical current to continuously regener-
typical pharmaceutical water purification system contains several ate the ion exchange resin simultaneously with the water
unit operations designed to remove various components. The treatment process, eliminating the need to handle powerful
selection of the most appropriate system and its overall design are chemicals. Ion exchange units are normally used today to treat
crucial factors in ensuring that water of the correct quality is raw feed water prior to distillation or RO processing.
produced.(1,2) Reverse osmosis Water is forced through a semipermeable
To produce potable or drinking water, insoluble matter is first membrane in the opposite direction to normal osmotic diffusion.
W removed from a water supply by coagulation, settling (clarifica-
tion), and filtering processes. Pathogenic microorganisms present
Typically, membranes range between 1–10 Å and reject not only
organic compounds, bacteria and viruses, but also 90–99% of
are then destroyed by aeration, chlorination, or some other means. all ions. It is common to use double-pass RO systems with two
Water may also be rendered free of viable pathogenic microorgan- filtration stages connected in series. Such systems meet require-
isms by active boiling for 15–20 minutes. Activated carbon filters ments for USP purified water and WFI. However, EU regulations
are employed to remove chlorine and many dissolved organic do not allow RO to be used as a final treatment step for the
materials found in water, although they may become a breeding production of WFI.
ground for microorganisms. The palatability of the water is Membrane filtration Membrane filters are surface-type filters,
improved by aeration and charcoal filtration. which stop particles larger than the pore size at the upstream
Purified water suitable for use in pharmaceutical formulations is surface of the polymeric membrane. Microfiltration uses
usually prepared by purifying potable water by one of several membranes with pores in the 0.1–1.0 mm range, which can filter
processes, such as distillation, deionization, or RO.(1,3–8) out particles of dust, activated carbon, ion exchange resin fines,
The quality attributes of WFI are stricter than those for purified and most microorganisms. Ultrafiltration uses membranes that
water. Consequently, the preparation methods typically vary in the reject not only solid particles but also dissolved matter with a
last stage to ensure good control of WFI quality. Methods for the high molecular weight. The ‘molecular weight cut-off’ point of
production of WFI are the subject of current debate. The PhEur 6.3 such membranes varies in the range 10 000–100 000 Da, and
indicates that only distillation would give assurance of consistent bacteria, endotoxins, colloidal contaminants, and large organic
supply of the appropriate quality, but permits distillation, ion molecules can be removed.
Water 76 9
18 Comments
15 Handling Precautions
In most pharmacopeias, the term ‘water’ now refers to purified or
Observe normal precautions appropriate to the circumstances and distilled water.
quantity of material handled. Without further purification, ‘water’ may be unsuitable for
certain pharmaceutical applications; for example, the presence of
calcium in water affects the viscosity and gel strength of algins and
16 Regulatory Status
pectin dispersions, while the use of potable water affects the clarity
Included in nonparenteral and parenteral medicines licensed in the and quality of cough mixtures, and the stability of antibiotic liquid
UK and USA. preparations.
Water commonly contains salts of aluminum, calcium, iron,
magnesium, potassium, sodium, and zinc. Toxic substances such as
17 Related Substances arsenic, barium, cadmium, chromium, cyanide, lead, mercury, and
Bacteriostatic water for injection; carbon dioxide-free water; de- selenium may constitute a danger to health if present in excessive
aerated water; hard water; soft water; sterile water for inhalation; amounts. Ingestion of water containing high amounts of calcium
sterile water for injection; sterile water for irrigation; water for and nitrate is also contraindicated. National standards generally
injection (WFI). specify the maximum limits for these inorganic substances in
Bacteriostatic water for injection potable water. Limits have also been placed on microorganisms,
Comments The USP 32 describes bacteriostatic water for injection detergents, phenolics, chlorinated phenolics, and other organic
as sterile water for injection that contains one or more suitable substances. The WHO(11) and national bodies have issued guide-
antimicrobial agents. lines for water quality, although many countries have their own
standards for water quality embodied in specific legislation.(12) See
Carbon dioxide-free water Table IV.
Comments Purified water that has been boiled vigorously for 5
minutes and allowed to cool while protecting it from absorption
of atmospheric carbon dioxide. Table IV: Limits for inorganic substances in potable water (mg/L).
Control of microbiological contamination is critical for waters 5 Cross J. Steam sterilisable ultrafiltration membranes. Manuf Chem
used in preparation of pharmaceuticals, as proliferation of 1989; 60(3): 25–27.
microorganisms can potentially occur during all stages of manu- 6 Horry JM, Cross JR. Purifying water for ophthalmic and injectable
facture, storage, or distribution. Suitable control is achieved by preparations. Pharm J 1989; 242: 169–171.
ensuring that the water system is well designed and well maintained. 7 Smith VC. Pure water. Manuf Chem 1990; 61(3): 22–24.
Purified water that is produced, stored, and circulated at ambient 8 Burrows WD, Nelson JH. IV fluidmakers: preparation of sterile water
for injection in a field setting. J Parenter Sci Technol 1993; 47(3): 124–
temperatures is susceptible to the establishment of biofilms;
129.
therefore, frequent monitoring, high usage, correct flow rate, and
9 Walker A. Drinking water – doubts about quality. Br Med J 1992; 304:
appropriate sanitization are all factors that require consideration to
175–178.
ensure that water is satisfactory.(13) 10 Lewis RJ, ed. Sax’s Dangerous Properties of Industrial Materials, 11th
Monitoring of the whole system is essential in order to edn. New York: Wiley, 2004; 3692.
demonstrate that correct microbiological quality is achieved. For 11 World Health Organization. Guidelines for Drinking-water Quality,
WFI, the recommended methodology is membrane filtration vol. 1: Recommendations. Geneva: WHO, 1984.
(0.45 mm) as a large sample size (100–300 mL) is required. For 12 Statutory Instrument 1147. The water supply (water quality) regula-
purified water, membrane filtration or plate count methods are tions 1989. London: HMSO, 1989. http://www.opsi.gov.uk/ (accessed
typically used depending on the quality requirements of the system. 27 February 2009).
It is important to set appropriate target, alert, and action limits to 13 Riedewald F. Biofilms in pharmaceutical waters. Pharm Eng 1997;
serve as an indication of action required to bring the quality of Nov/Dec: 8–18.
water back under control. It is recognized that limits are not 14 Food and Drug Administration. Guide to Inspections of High Purity
intended as pass/fail criteria for water or product batches; however, Water Systems. Washington, DC: FDA, 1993. http://www.fda.gov/ora/
an investigation regarding the implications should be conducted.(14) inspect_ref/igs/high.html (accessed 27 February 2009).
Validation is conducted to provide a high level of assurance that
the water production and distribution system will consistently 20 General References
produce water conforming to a defined quality specification. The
Collentro WV, ed. Pharmaceutical Water: System Design, Operation and
validation process serves to qualify the design (DQ), installation
Validation. Buffalo Grove, IL: Interpharm Press, 1999.
(IQ), operation (OQ), and performance (PQ) of the system. The
European Directorate for the Quality of Medicines and Healthcare
extent of monitoring data required should be defined, with (EDQM). European Pharmacopoeia – State Of Work Of International
consideration given to whether validation to FDA guidelines is Harmonisation. Pharmeuropa 2009; 21(1): 142–143. http://www.edq-
required.(14) It is also important to have an ongoing control m.eu/site/-614.html (accessed 27 February 2009).
program with respect to maintenance, and periodic reviews of the Rössler R. Water and air, two important media in the manufacture of sterile
performance of the water system. pharmaceuticals, with regard to the GMP. Drugs Made Ger 1976; 19:
The PubChem Compound ID (CID) for water is 962. 130–136.
Santoro M, Maini C. Which water for pharmaceutical use? Eur J Parenter
19 Specific References Pharm Sci 2003; 8: 15–20.
1 Thomas WH, Harvey H. Achieving purity in pharmaceutical water.
Manuf Chem Aerosol News 1976; 47(10): 32, 36, 39, 40. 21 Authors
2 McWilliam AJ. High purity water distribution systems. Pharm Eng
1995; Sept/Oct: 54–71. D Dubash, U Shah.
3 Honeyman T. Purified water for pharmaceuticals. Manuf Chem 1987;
58(3): 53, 54, 57, 59.
22 Date of Revision
4 Cross J. Treating waters for the pharmaceutical industry. Manuf Chem
1988; 59(3): 34–35. 27 February 2009.
SECTION 1: Identification
1.1. Identification
Product form : Substance
Substance name : Sodium Carbonate, Anhydrous
CAS-No. : 497-19-8
Product code : LC22965
Formula : Na2CO3
1.2. Recommended use and restrictions on use
Use of the substance/mixture : For laboratory and manufacturing use only.
Recommended use : Laboratory chemicals
Restrictions on use : Not for food, drug or household use
1.3. Supplier
LabChem Inc
Jackson's Pointe Commerce Park Building 1000, 1010 Jackson's Pointe Court
Zelienople, PA 16063 - USA
T 412-826-5230 - F 724-473-0647
info@labchem.com - www.labchem.com
GHS07
Signal word (GHS-US) : Warning
Hazard statements (GHS-US) : H315 - Causes skin irritation
H319 - Causes serious eye irritation
Precautionary statements (GHS-US) : P264 - Wash exposed skin thoroughly after handling.
P280 - Wear eye protection, protective gloves.
P302+P352 - IF ON SKIN: Wash with plenty of soap and water.
P305+P351+P338 - If in eyes: Rinse cautiously with water for several minutes. Remove contact
lenses, if present and easy to do. Continue rinsing
P332+P313 - If skin irritation occurs: Get medical advice/attention.
P337+P313 - If eye irritation persists: Get medical advice/attention.
P362 - Take off contaminated clothing and wash before reuse.
2.3. Other hazards which do not result in classification
Other hazards not contributing to the : None.
classification
2.4. Unknown acute toxicity (GHS US)
Not applicable
Hand protection:
Wear protective gloves.
Eye protection:
Chemical goggles or safety glasses
Respiratory protection:
Respiratory protection not required in normal
conditions
Other information:
Do not eat, drink or smoke during use.
Odor : odorless
Odor threshold : No data available
pH : 11.6
Melting point : No data available
Freezing point : No data available
Boiling point : 1600 °C
Flash point : No data available
Relative evaporation rate (butyl acetate=1) : No data available
Flammability (solid, gas) : Non flammable.
Vapor pressure : No data available
Relative vapor density at 20 °C : No data available
Relative density : No data available
Specific gravity / density : 2.53 g/cm³
Molecular mass : 105.99 g/mol
Solubility : No data available
Log Pow : No data available
Auto-ignition temperature : No data available
Decomposition temperature : No data available
Viscosity, kinematic : No data available
Viscosity, dynamic : No data available
Explosion limits : No data available
Explosive properties : Not applicable.
Oxidizing properties : None.
9.2. Other information
No additional information available
Potential Adverse human health effects and : Based on available data, the classification criteria are not met.
symptoms
Symptoms/effects after inhalation : Coughing.
Symptoms/effects after skin contact : Causes skin irritation.
Symptoms/effects after eye contact : Causes serious eye irritation.
Symptoms/effects after ingestion : Vomiting. Nausea.
Chronic symptoms : Not available.
EU-Regulations
No additional information available
National regulations
Sodium Carbonate, Anhydrous (497-19-8)
Listed on the Canadian IDL (Ingredient Disclosure List)
Hazard Rating
Health : 1 Slight Hazard - Irritation or minor reversible injury possible
Flammability : 0 Minimal Hazard - Materials that will not burn
Physical : 0 Minimal Hazard - Materials that are normally stable, even under fire conditions, and will NOT
react with water, polymerize, decompose, condense, or self-react. Non-Explosives.
Personal protection : B
B - Safety glasses, Gloves
SDS US LabChem
Information in this SDS is from available published sources and is believed to be accurate. No warranty, express or implied, is made and LabChem Inc assumes no liability resulting from the use of this
SDS. The user must determine suitability of this information for his application.
1.4 Emergency telephone number +44 (0)1689 877020 (09:00 - 16:00 Monday to Friday)
SECTION 2: HAZARD IDENTIFICATION
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 [EU-GHS/CLP
Eye. Irrit. 2, H319
Skin. Irrit. 2, H315
2.2 Label elements
Signal Word: Hazard Pictograms:
WARNING
Hazard Statements:
Precautionary Statements:
Disposal
P501 Dispose of contents/container to licensed waste disposal site.
Response
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and
easy to do. Continue rinsing.
P302 + P352 IF ON SKIN: Wash with plenty of soap and water.
P332 + P313 If skin irritation occurs: Get medical advice/attention.
Storage
P102 Keep out of reach of children.
2.3 Other hazards
EUH none None known
Aspiration hazard
no data available
Potential health effects
Inhalation May be harmful if inhaled. Causes respiratory tract irritation.
Ingestion Harmful if swallowed.
Skin May be harmful if absorbed through skin. Causes skin irritation.
Eyes Causes eye burns.
Signs and Symptoms of Exposure
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Additional Information
RTECS: DB6825000
Sodium C12-C15 TOXIC DOSE 1 - LD 50 >2000 mg/kg (oral rat)
Alcohol Ether INHALATION
Sulphate May cause irritation to the respiratory system.
INGESTION
May cause discomfort if swallowed.
SKIN CONTACT
Irritating to skin.
EYE CONTACT
May cause severe irritation to eyes.
No information regarding interactions between the ingredients in this mixture is available, therefore, the information shown
above is separately reported for each relevant ingredient used in the mixture even though it may be present below its
concentration limit and represent no toxicity in the mixture as a whole.
EU Legislation
Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling
and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending
Regulation (EC) No 1907/2006.
Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration,
Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending
Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well
as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC, including
amendments.
Guidance
GLOSSARY: PPE Personal protective equipment. N/A Not applicable. N/K Not known OES Occupational exposure limit
TWA Time weighted average W/V Weight to volume
The data contained in this Safety Data Sheet has been supplied for the purpose of protecting the health and safety of industrial and commercial users who are deemed capable of understanding and acting on the information
provided.
ANIMAL TESTING: Teepol Products (UK) do not test their finished products on animals.
The information contained in this document is based on information believed to be correct on the date of issue. No warranty or representation, expressed or
implied, is made as to the accuracy or completeness of this information. The user assumes all liability for any damage or injury resulting from abnormal use, from
the failure to adhere to recommended practises, or from hazards inherent in the nature of the product. In accordance with our policy of incorporating technical
improvemets, we reserve the right to amend any specification without notice.
TSCA: TSCA 8(b) inventory; Water; Ethyl Alcohol 95% Sidoarjo - Indonesia
Website: www.onemed.co.id
Toxicological Data on Ingredients: Ethyl alcohol: ORAL (LD50): Acute: 7060 mg/kg [Rat]. 3450 mg/kg [Mouse].
VAPOR (LC50): Acute: 20000 ppm 8 hours [Rat]. 39000 mg/m 4 hours [Mouse].
p. 1
The substance is toxic to blood, the reproductive system, liver, upper respiratory tract, skin, central nervous
Skin Contact:
In case of contact, immediately flush skin with plenty of water. Cover the irritated skin with an emollient. Remove
contaminated clothing and shoes. Cold water may be used.Wash clothing before reuse. Thoroughly clean shoes
before reuse. Get medical attention.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get
medical attention if symptoms appear.
Serious Inhalation:
Evacuate the victim to a safe area as soon as possible. Loosen tight clothing such as a collar, tie, belt or
waistband. If breathing is difficult, administer oxygen. If the victim is not breathing, perform mouth-to-mouth
resuscitation. Seek medical attention.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an
unconscious person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention if
symptoms appear.
Auto-Ignition Temperature: The lowest known value is 363°C (685.4°F) (Ethyl alcohol 95% ).
Flammable Limits: The greatest known range is LOWER: 3.3% UPPER: 19% (Ethyl alcohol 95% )
p. 2
Special Remarks on Fire Hazards:
Containers should be grounded. CAUTION: MAY BURN WITH NEAR INVISIBLE FLAME Vapor may travel
considerable distance to source of ignition and flash back. May form explosive mixtures with air.
Contact with Bromine pentafluoride is likely to cause fire or explosion.
Ethanol ignites on contact with chromyl chloride.
Ethanol ignites on contact with iodine heptafluoride gas.
It ignites than explodes upon contact with nitrosyl perchlorate.
Additon of platinum black catalyst caused ignition.
(Ethyl alcohol 95% )
Large Spill:
Flammable liquid.
Keep away from heat. Keep away from sources of ignition. Stop leak if without risk. Absorb with DRY earth,
sand or other non-combustible material. Do not touch spilled material. Prevent entry into sewers, basements or
confined areas; dike if needed. Be careful that the product is not present at a concentration level above TLV.
Check TLV on the MSDS and with local authorities.
Storage:
Store in a segregated and approved area. Keep container in a cool, well-ventilated area. Keep container tightly
closed and sealed until ready for use. Avoid all possible sources of ignition (spark or flame). Do not store above
23°C (73.4°F).
p. 3
Provide exhaust ventilation or other engineering controls to keep the airborne concentrations of vapors below their
respective threshold limit value. Ensure that eyewash stations and safety showers are proximal to the
work-station location.
Personal Protection:
Splash goggles. Lab coat. Vapor respirator. Be sure to use an approved/certified respirator or equivalent.
Gloves.
Exposure Limits:
Ethyl alcohol 200 Proof
TWA: 1900 (mg/m3) from OSHA (PEL) [United States]
TWA: 1000 (ppm) from OSHA (PEL) [United States]
TWA: 1900 (mg/m3) from NIOSH [United States]
TWA: 1000 (ppm) from NIOSH [United States]
TWA: 1000 (ppm) [United Kingdom (UK)]
TWA: 1920 (mg/m3) [United Kingdom (UK)]
TWA: 1000 STEL: 1250 (ppm) [Canada]
Consult local authorities for acceptable exposure limits.
Odor:
Alcohol like. Mild to strong. Like wine or
whiskey; Ethereal, vinous. Pleasant.
Boiling Point: The lowest known value is 78.5°C (173.3°F) (Ethyl alcohol 95% ). Weighted average: 79.58°C (175.2°F)
Melting Point: May start to solidify at -114.1°C (-173.4°F) based on data for: Ethyl alcohol 95% ) .
Critical Temperature: The lowest known value is 243°C (469.4°F) (Ethyl alcohol 95% ).
Vapor Pressure: The highest known value is 5.7 kPa (@ 20°C) (Ethyl alcohol 95% ). Weighted average: 5.53 kPa (@
20°C)
Vapor Density: The highest known value is 1.59 (Air = 1) (Ethyl alcohol 95% ). Weighted average: 1.54 (Air = 1)
p. 4
Dispersion Properties: See solubility in water, methanol, diethyl ether, acetone.
Solubility:
Easily soluble in cold water, hot water, methanol, diethyl ether.
Soluble in acetone.
Incompatibility with various substances: Reactive with oxidizing agents, acids, alkalis.
Toxicity to Animals: Acute oral toxicity (LD50): 3632 mg/kg (Mouse) (Calculated value for the mixture).
p. 5
Special Remarks on Toxicity to Animals:
Lowest Published Dose/Conc:
LDL[Human] - Route: Oral; Dose: 1400 mg/kg
LDL[Human child] - Route: Oral; Dose: 2000 mg/kg
LDL[Rabbit] - Route: Skin; Dose: 20000 mg/kg (Ethyl alcohol 95% )
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may
arise.
Toxicity of the Products of Biodegradation: The product itself and its products of degradation are not toxic.
p. 6
Section 15: Other Regulatory Information
Other Regulations: OSHA: Hazardous by definition of Hazard Communication Standard (29 CFR 1910.1200).
Other Classifications:
WHMIS (Canada):
CLASS B-2: Flammable liquid with a flash point lower than 37.8°C (100°F).
CLASS D-2B: Material causing other toxic effects (TOXIC).
DSCL (EEC):
R11- Highly flammable.
S7- Keep container tightly closed.
S16- Keep away from sources of ignition - No
smoking.
HMIS (U.S.A.):
Health Hazard: 2
Fire Hazard: 3
Reactivity: 0
Personal Protection: h
Health: 2
Flammability: 3
Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves.
Lab coat.
Vapor respirator. Be sure to use an
approved/certified respirator or
equivalent. Wear appropriate respirator
when ventilation is inadequate.
Splash goggles.
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we
assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the
information for their particular purposes.
p.7
He a lt h 0
0 0
Fire
0 0
Re a c t iv it y 0
P e rs o n a l A
P ro t e c t io n
p. 1
Skin Contact: Not applicable.
Serious Skin Contact: Not available.
Inhalation: Not applicable.
Serious Inhalation: Not available.
Ingestion: Not Applicable
Serious Ingestion: Not available.
Small Spill: Mop up, or absorb with an inert dry material and place in an appropriate waste disposal container.
Large Spill: Absorb with an inert material and put the spilled material in an appropriate waste disposal.
Precautions: No specific safety phrase has been found applicable for this product.
Storage: Not applicable.
p. 2
Odor: Odorless.
Taste: Not available.
Molecular Weight: 18.02 g/mole
Color: Colorless.
pH (1% soln/water): 7 [Neutral.]
Boiling Point: 100°C (212°F)
Melting Point: Not available.
Critical Temperature: Not available.
Specific Gravity: 1 (Water = 1)
Vapor Pressure: 2.3 kPa (@ 20°C)
Vapor Density: 0.62 (Air = 1)
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: Not applicable
Solubility: Not Applicable
p. 3
Special Remarks on Chronic Effects on Humans: Not available.
Special Remarks on other Toxic Effects on Humans: Not available.
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental control regulations.
p. 4
Protective Equipment:
Not applicable. Lab coat. Not applicable. Safety glasses.
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
p. 5
Hydrochloric Acid MSDS
Effective Date: December 03, 2012
24 Hour Emergency Contact:
ChemTel: (800)255-3924
www.pioneerforensics.com
2. HAZARDS IDENTIFICATION
Emergency Overview: DANGER! Corrosive. Causes severe skin, eye, and digestive tract burns. Harmful if
swallowed. Mist or vapor extremely irritating to eyes and respiratory tract.
OSHA Regulatory Status: This product is considered a "Hazardous Chemical" as defined by the OSHA Hazard
Communication Standard, 29 CFR 1910.1200.
Inhalation: Corrosive. May cause damage to mucous membranes in nose, throat, lungs and bronchial
system.
Ingestion: Corrosive. Harmful if swallowed. May produce burns to the lips, oral cavity, upper airway,
esophagus and digestive tract.
Eye Contact: Corrosive. Causes severe burns. Vapor or spray may cause eye damage, impaired sight or
blindness.
Chronic Health Effects: Corrosive. Prolonged contact causes serious tissue damage.
Potential Environmental May affect the acidity (pH) in water with risk of harmful effects to aquatic organisms.
Effects:
Chemical Formula % by
Components CAS# Formula Weight Hazardous Weight
Hydrochloric Acid 7647-01-0 HCl 36.46 Yes 36.5 - 38.0
Water 7732-18-5 H2O 18.02 No 62.0 - 63.5
Inhalation: Remove to fresh air. If breathing is difficult, administer oxygen. If the victim is not
breathing, perform mouth-to-mouth resuscitation. Get medical attention immediately.
Ingestion: Do not induce vomiting. If vomiting occurs, keep head low so that vomit does not enter
lungs. Never give anything by mouth to an unconscious person. GET MEDICAL
ATTENTION IMMEDIATELY.
Skin Contact: Flush affected area with plenty of water for at least 15 minutes. Remove contaminated
clothing and shoes. Wash clothing before reuse. Get medical attention immediately.
Eye Contact: Check for and remove contact lenses. Immediately flush eyes with gentle but large stream
of water for at least 15 minutes, lifting lower and upper eyelids occasionally. Get medical
attention immediately.
General Advice: In the case of accident or if you feel unwell, seek medical advice immediately (show the
label where possible). Ensure that medical personnel are aware of the material(s) involved
and take precautions to protect themselves. Show this safety data sheet to the doctor in
attendance.
Specific Hazards: Fire may produce irritating, corrosive, and/or toxic gases.
Special Protective Equipment As in any fire, wear MSHA/NIOSH approved (or equivalent) self-contained positive pressure
For Firefighters: or pressure-demand breathing apparatus and full protective gear.
Specific Methods: Use water spray to cool unopened containers. Cool containers exposed to flames with
flooding quantities of water until well after the fire is out. In the event of fire and/or explosion
do not breathe fumes.
Personal Precautions: Ventilate area of leak or spill. Isolate hazard area and keep unnecessary and unprotected
personnel away from the area of the leak or spill. Keep upwind. Keep out of low areas.
Wear appropriate personal protective equipment as specified in the Exposure Control and
Personal Protection Section 8. Avoid contact with eyes, skin, and clothing.
Environmental Precautions: Prevent further leakage or spillage if safe to do so. Do not contaminate water. Avoid
discharge into drains, water courses or onto the ground. In case of large spill, dike if
needed.
Methods for Containment: Stop the flow of material, if this is without risk. Prevent entry into waterways, sewer,
basements or confined areas. Dike the spilled material, where this is possible.
Methods for Cleaning Up: Absorb spill with an inert material (e.g. vermiculite, dry sand, earth, cloth, fleece), and place
in a suitable non-combustible container for reclamation or disposal. Do not use combustible
materials, such as sawdust. Clean contaminated surface thoroughly. Neutralize spill area
and washings with soda ash or lime. Never return spills in original containers for re-use.
Clean up in accordance with all applicable regulations.
Handling: Wear personal protective equipment (see section 8). Use only in well-ventilated areas.
Provide sufficient air exchange and/or exhaust in work rooms. Avoid contact with skin, eyes
and clothing. Do not breathe vapors or spray mist. Do not ingest. When using, do not eat,
smoke, or drink. Keep away from incompatible materials. Handle in accordance with good
industrial hygiene and safety practice. Wash thoroughly after handling. Containers of this
material may be hazardous when empty since they retain product residues (vapors, liquids).
Observe all warnings and precautions listed for the product Use caution when combining
with water. DO NOT add water to acid. ALWAYS add acid to water while stirring to prevent
release of heat, steam, and fumes.
Storage: Store in a cool, dry, ventilated area away from incompatible materials. Store in original
container. Keep containers tightly closed and upright. Keep away from food, drink and
animal feedingstuffs. Keep out of the reach of children.
Engineering Controls: Ensure adequate ventilation. Ventilation rates should be matched to conditions. If
applicable, use process enclosures, local exhaust ventilation, or other engineering controls
Eye/Face Protection: Wear safety glasses with side shields or goggles and a face shield.
Skin Protection: Wear appropriate chemical resistant clothing (with long sleeves) and appropriate chemical
resistant gloves.
Respiratory Protection: If engineering controls do not maintain airborne concentrations below recommended
exposure limits (where applicable) or to an acceptable level (in countries where exposure
limits have not been established), an approved respirator must be worn. Respirator type:
Chemical respirator with acid gas cartridge. Use a positive-pressure air-supplied respirator
if there is any potential for an uncontrolled release, exposure levels are not known, or any
other circumstances where air-purifying respirators may not provide adequate protection.
General Hygiene Avoid contact with skin, eyes and clothing. When using, do not eat, drink or smoke. Always
Considerations: observe good personal hygiene measures, such as washing after handling the material and
before eating, drinking, and/or smoking. Routinely wash work clothing and protective
equipment to remove contaminants. Provide eyewash station and safety shower.
Incompatible Materials: Bases, metals, oxidizing agents, acids, amines, reducing agents, organic materials
Possibility of Hazardous Can react vigorously, violently or explosively with incompatible materials listed above.
Reactions:
Acute Effects: Strongly corrosive. May cause deep tissue damage. Harmful if swallowed.
Local Effects: Causes severe burns. Mist or vapor extremely irritating to eyes and respiratory tract.
Chronic Effects: Corrosive. Prolonged or repeated skin contact causes serious tissue damage.
Carcinogenic Effects: This product is not considered to be a carcinogen by IARC, ACGIH, NTP, or OSHA.
Mutagenicity: No data available to indicate product or any components present at greater than 0.1% are
mutagenic or genotoxic.
Teratogenic Effects: No data available to indicate product or any components present at greater than 0.1% may
cause birth defects.
Target Organs and Symptoms: Corrosive effects. Mucus membranes, skin, eyes, kidneys, liver, respiratory tract
Ecotoxicity: This product may affect the acidity (pH) in water with risk of harmful effects to aquatic
organisms.
Environmental Effects: An environmental hazard cannot be excluded in the event of unprofessional handling or
disposal.
Disposal Instructions: Dispose of this material and its container to hazardous or special waste collection point.
Incinerate the material under controlled conditions in an approved incinerator. All wastes
must be handled in accordance with local, state and federal regulations.
Contaminated Packaging: Since emptied containers retain product residue, follow label warnings even after container
is emptied. Offer rinsed packaging material to local recycling facilities.
Waste Codes: D002: Waste corrosive material (pH ≤ 2 or pH ≥12.5, or corrosive to steel)
DOT:
UN Number: UN1789
Hazard Class: 8
Packaging Group: II
OSHA: This product is considered a "Hazardous Chemical" as defined by the OSHA Hazard
Communication Standard, 29 CFR 1910.1200.
*A "Yes" indicates that the listed component(s) of this product comply with the inventory requirements administered by the
governing country(s)
Disclaimer: Pioneer Forensics LLC provides the information in this Material Safety Data Sheet in the
belief that it is reliable but assumes no responsibility for its completeness or accuracy. The
physical properties reported in this MSDS are obtained from the literature and do not
constitute product specifications. Pioneer Forensics LLC makes and gives no
representations or warranties with respect to the information contained herein or the product
to which it refers, whether express, implied, or statutory, including without limitation,
warranties of accuracy, completeness, merchantability, non-infringement, performance,
safety, suitability, stability, and fitness for a particular purpose. No warranty against
infringement of any patent, copyright or trademark is made or implied. This MSDS is
intended only as a guide to the appropriate handling of the material by a properly trained
person. It shall be the user's responsibility to develop proper methods of handling and
personal protection based on the actual conditions of use. Accordingly, Pioneer Forensics
LLC assumes no liability whatsoever for the use of or reliance upon this information
including results obtained, incidental or consequential damages, or lost profits.